Cargando…
Drug repositioning by merging active subnetworks validated in cancer and COVID-19
Computational drug repositioning aims at ranking and selecting existing drugs for novel diseases or novel use in old diseases. In silico drug screening has the potential for speeding up considerably the shortlisting of promising candidates in response to outbreaks of diseases such as COVID-19 for wh...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494853/ https://www.ncbi.nlm.nih.gov/pubmed/34615934 http://dx.doi.org/10.1038/s41598-021-99399-2 |